These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 6813498

  • 1. Comparative pharmacokinetics of parenteral and oral gold compounds.
    Gottlieb NL.
    J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
    [Abstract] [Full Text] [Related]

  • 2. Metabolism and distribution of gold compounds.
    Gottlieb NL.
    J Rheumatol Suppl; 1979; 5():2-6. PubMed ID: 114646
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the kinetics of parenteral and oral gold.
    Gottlieb NL.
    Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacokinetics of oral and injectable gold compounds.
    Blocka KL, Paulus HE, Furst DE.
    Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
    [Abstract] [Full Text] [Related]

  • 5. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
    Blocka K.
    Am J Med; 1983 Dec 30; 75(6A):114-22. PubMed ID: 6419592
    [Abstract] [Full Text] [Related]

  • 6. Gold excretion and retention during auranofin treatment: a preliminary report.
    Gottlieb NL.
    J Rheumatol Suppl; 1979 Dec 30; 5():61-7. PubMed ID: 385875
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology of auranofin: overview and update.
    Gottlieb NL.
    Scand J Rheumatol Suppl; 1986 Dec 30; 63():19-28. PubMed ID: 3110942
    [Abstract] [Full Text] [Related]

  • 8. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
    Furst DE, Dromgoole SH.
    Clin Rheumatol; 1984 Mar 30; 3 Suppl 1():17-24. PubMed ID: 6432409
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of auranofin in animals.
    Intoccia AP, Flanagan TL, Walz DT, Gutzait L, Swagzdis JE, Flagiello J, Hwang BY, Dewey RH, Noguchi H.
    J Rheumatol Suppl; 1982 Mar 30; 8():90-8. PubMed ID: 6813497
    [Abstract] [Full Text] [Related]

  • 10. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT, Griswold DE, DiMartino MJ, Bumbier EE.
    J Rheumatol; 1983 Feb 30; 10(1):117-20. PubMed ID: 6405031
    [Abstract] [Full Text] [Related]

  • 11. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
    Blocka K, Furst DE, Landaw E, Dromgoole S, Blomberg A, Paulus HE.
    J Rheumatol Suppl; 1982 Feb 30; 8():110-9. PubMed ID: 6813473
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of gold sodium thiomalate.
    Waller ES, Massarella JW, Crout JE, Yakatan GJ.
    Res Commun Chem Pathol Pharmacol; 1982 Jul 30; 37(1):33-47. PubMed ID: 6812186
    [Abstract] [Full Text] [Related]

  • 13. [The pharmacology of gold compounds].
    Juan H.
    Wien Klin Wochenschr Suppl; 1984 Jul 30; 156():7-13. PubMed ID: 6442062
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.
    Walz DT, Griswold DE, DiMartino MJ, Bumbier EE.
    J Rheumatol; 1980 Jul 30; 7(6):820-4. PubMed ID: 6782245
    [Abstract] [Full Text] [Related]

  • 15. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E, Munthe E, Guldal G, Aaseth J.
    Scand J Rheumatol Suppl; 1979 Jul 30; (28):28-36. PubMed ID: 109914
    [Abstract] [Full Text] [Related]

  • 16. The pharmacological profile of auranofin, an orally active gold compound.
    Walz DT, DiMartino MJ, Griswold DE.
    Scand J Rheumatol Suppl; 1983 Jul 30; 51():16-25. PubMed ID: 6426049
    [Abstract] [Full Text] [Related]

  • 17. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC, Osborn TG.
    Clin Pharm; 1984 Jul 30; 3(2):121-7. PubMed ID: 6426843
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
    Furst DE.
    Pharmacotherapy; 1983 Jul 30; 3(5):284-98. PubMed ID: 6417628
    [Abstract] [Full Text] [Related]

  • 19. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
    Walz DT, Griswold DE, DiMartino MJ, Bumbier EE.
    J Rheumatol Suppl; 1979 Jul 30; 5():56-60. PubMed ID: 114638
    [Abstract] [Full Text] [Related]

  • 20. Biologic actions and pharmacokinetic studies of auranofin.
    Walz DT, DiMartino MJ, Griswold DE, Intoccia AP, Flanagan TL.
    Am J Med; 1983 Dec 30; 75(6A):90-108. PubMed ID: 6318557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.